ArticleInternational journal of implant dentistry2025
High-intensity focused ultrasound for biofilm debridement, an in vitro proof-of-concept using Ti-attached Streptococcus mutans.
Article in International journal of implant dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionPeri-implantitis (PI) is a biofilm-related condition driven by bacterial colonization on dental implant surfaces, leading to inflammation of the peri-implant connective tissue and progressive bone loss. Despite advancements, effective strategies for eradicating these biofilms remain elusive. While high-intensity focused ultrasound (HIFU) has been popularized in medicine, its effects on dental implant-attached biofilms remain unclear. This study presents in vitro findings on the effects of HIFU treatment on titanium (Ti)-attached Streptococcus mutans (S. mutans) biofilms and evaluates its impacts on the surface roughness and chemical composition of the Ti disc substrates.
methodsTo optimise the HIFU parameters, four quadrants of a pair of Ti discs [machined (M) and alumina grit blasted (AB)] were marked using laser etching (MD Waterlase, US). HIFU beams, generated by a 254 kHz transducer and operated at intensities of 0 W, 10 W, 20 W, and 30 W, were applied to each quadrant for 2 min (min) in a water medium. The roughness of the treated surfaces was measured using Atomic Force Microscopy (AFM), and the surface composition was analyzed using Scanning Electron Microscope-Energy Dispersive Spectrometry (SEM-EDS). To investigate the biofilm debridement, 10-day-old S. mutans cultures were grown on 20 pairs of similar Ti discs, and then the optimized HIFU intensity of 20W was applied to five test pairs. Qualitative analyses were performed using a Dual Fluorescence/Reflection Confocal Laser Scanning Microscope (FRCLSM) and SEM imaging. Quantitative data on cell viability were collected using crystal violet (CV), (3-[4,5-dimethylthiazol-2-yl]-2,5 2,5-diphenyl tetrazolium bromide) (MTT), and flow cytometry (FCM) assays. Data from these test conditions were analyzed alongside cultures on biofilms that were untreated (control). Statistical data were calculated using ANOVA and appropriate t-tests for repeated measures.
resultsThe surface roughness of AB Ti discs showed a highest and significant increase (p < 0.05) following HIFU exposure at 20 W through three roughness parameters (Sa, Sq, and Sdr), compared to the controls (1207 nm, 1455 nm, 62% compared to 842 nm, 1042 nm and 30% respectively). This optimized HIFU treatment not only significantly reduced the bacterial counts of the biofilms (76% of total bacteria from M discs, 59% on AB discs in FCM assays) but also created areas of complete biofilm removal in SEM images.
conclusionThis study provides preliminary in vitro evidence that HIFU can remove bacterial biofilms. Further research is required to determine its feasibility as a potential non-surgical approach for the prevention and management of peri-implantitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.